1174. Phase 2 STRIVE Clinical Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrates Consistent Trough Concentrations Across Diverse Patient Popul...

מאת Flanagan, Shawn, Rubino, Christopher M, Sandison, Taylor
הוצא לאור ב Open Forum Infect Dis (2020)

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers

מאת Farr, Stephen J, Robinson, Cynthia Y, Rubino, Christopher M
הוצא לאור ב Clin Pharmacol (2015)

Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data

מאת Lakota, Elizabeth A., Ong, Voon, Flanagan, Shawn, Rubino, Christopher M.
הוצא לאור ב Antimicrob Agents Chemother (2018)

Erratum for Lakota et al., “Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data”

מאת Lakota, Elizabeth A., Ong, Voon, Flanagan, Shawn, Rubino, Christopher M.
הוצא לאור ב Antimicrob Agents Chemother (2019)

Determination of Appropriate Weight-Based Cutoffs for Empiric Cefazolin Dosing Using Data from a Phase 1 Pharmacokinetics and Safety Study of Cefazolin Administered for Surgical Pr...

מאת Schmitz, Michael L., Blumer, Jeffrey L., Cetnarowski, Wes, Rubino, Christopher M.
הוצא לאור ב Antimicrob Agents Chemother (2015)

Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods

מאת Zhang, Li, Wicha, Wolfgang W, Bhavnani, Sujata M, Rubino, Christopher M
הוצא לאור ב J Antimicrob Chemother (2019)

Worldwide Antimicrobial Susceptibility Patterns and Pharmacodynamic Comparisons of Gatifloxacin and Levofloxacin against Streptococcus pneumoniae: Report from the Antimicrobial Res...

מאת Jones, Ronald N., Rubino, Christopher M., Bhavnani, Sujata M., Ambrose, Paul G.
יצא לאור 2003

1417. Evaluating the Dissonance Between C(max) and AUC with Clinically Utilized Aminoglycoside (AG) Dosing Regimens: Use of Tobramycin (TOB) Against Pseudomonas aeruginosa (PA) as...

מאת Onufrak, Nikolas J, Bhavnani, Sujata M, Pogue, Jason M, Rubino, Christopher M
הוצא לאור ב Open Forum Infect Dis (2018)

A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers

מאת Pan, Lin, Belloni, Paula, Ding, Han Ting, Wang, Jianshuang, Rubino, Christopher M., Putnam, Wendy S.
הוצא לאור ב Adv Ther (2017)

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

מאת Bhavnani, Sujata M., Ambrose, Paul G., Hammel, Jeffrey P., Rubino, Christopher M., Drusano, George L.
הוצא לאור ב Antimicrob Agents Chemother (2016)

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

מאת Safir, M. Courtney, Bhavnani, Sujata M., Slover, Christine M., Ambrose, Paul G., Rubino, Christopher M.
הוצא לאור ב Antibiotics (Basel) (2020)

Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment

מאת Rubino, Christopher M., Bhavnani, Sujata M., Loutit, Jeffery S., Lohse, Brooke, Dudley, Michael N., Griffith, David C.
הוצא לאור ב Antimicrob Agents Chemother (2018)

Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against Itself

מאת Ambrose, Paul G., VanScoy, Brian, Conde, Haley, McCauley, Jennifer, Rubino, Christopher M., Bhavnani, Sujata M.
הוצא לאור ב Antimicrob Agents Chemother (2016)

1408. Population Pharmacokinetic (PK) Model to Describe Epithelial Lining Fluid (ELF) Penetration of ASN-1 and ASN-2 after ASN100 Administration to Healthy Subjects

מאת Van Wart, Scott A, Stevens, Christopher, Magyarics, Zoltan, Luperchio, Steven A, Rubino, Christopher M, Ambrose, Paul G
הוצא לאור ב Open Forum Infect Dis (2018)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

מאת Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
יצא לאור 2009

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

מאת Rubino, Christopher M., Forrest, Alan, Bhavnani, Sujata M., Dukart, Gary, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G.
יצא לאור 2010

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis to Support VL-2397 Dose Selection for a Phase 2 Trial in Patients with Invasive Aspergillosis

מאת Rubino, Christopher M, Smith, Larry R, Mammen, Mammen P, Hopkins, Andrew M, Lakota, Elizabeth A, Sullivan, Sean M
הוצא לאור ב Open Forum Infect Dis (2017)

Time for Precision: A World Without Susceptibility Breakpoints

מאת Bader, Justin C, Lakota, Elizabeth A, Andes, David R, Rubino, Christopher M, Ambrose, Paul G, Bhavnani, Sujata M
הוצא לאור ב Open Forum Infect Dis (2018)

Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution

מאת Lakota, Elizabeth A., Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Bhavnani, Sujata M., Ambrose, Paul G., Rubino, Christopher M.
הוצא לאור ב Antimicrob Agents Chemother (2019)

Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients

מאת Schmitz, Michael L., Rubino, Christopher M., Onufrak, Nikolas J., Martinez, Diana Valencia, Licursi, Diane, Karpf, Angela, Cetnarowski, Wes
הוצא לאור ב J Clin Pharmacol (2020)